New Technical Report is Kraig Biocraft Laboratories (KBLB) - Why Are Investor Interest & Buzz Growing?

Listen with webReader

New Technical Report is Kraig Biocraft Labororatories Inc. (KBLB)We know biotechs and KBLB needs to be put immediately on your watchlist tomorrow morning as the buzz is starting to grow once again in this very popular company. You know we love following unique biotech companies and have witnessed some remarkable stories proven by our past due diligence reports. Can KBLB be added to our hall of fame list of biotechs? This might be very possible if the current technicals continue to reverse in trend and if the company continues to update the large shareholder base with more promising news. Before we look into why microcap investors are so bullish with the recent company developments, lets focus on this novelty technology and the current technicals!

What is the fuss about Kraig Biocraft Laboratories, Inc. Novelty Science and Technology?

Kraig Biocraft Laboratories, Inc. (KBLB) is applying its proprietary genetic engineering technology to find solutions in the areas of material science. They are developing commercial polymers (fibers) which they believe will have broad applications for the multi billion dollar textile industry and in the market place for high strength materials. Their investments in genetic research are focused on product development and innovative near term solutions to the practical problems of our world. These investments have recently resulted in our widely heralded success in developing recombinant spider silks and the first ever technology for commercial production of the same!

Looking at the technical chart below, KBLB has slowly bounced back after dipping to a low of $.082 back in mid August. Since then it has reversed in technical trend heading back up to a high of $.11. Last week KBLB closed flat at $.101. However we noticed that the investor interest and buzz has been growing ever since their last announcement earlier this month! Volume has recently spiked and microcap investors are pouring back into this company. After this corporate development and finding a bottom, KBLB has shown us that this support is real! With support comes accumulation and shown in the chart below. The consolidation is holding KBLB at $.10 and can KBLB finally find its next leg this week? With the slow and steady reversal from $.082 closing down a whooping -54% from its 52-week high of $.22, we might be in store for a technical breakout! Now why are microcap investors buzzing again this month? Lets find out below!

Why are microcap investors so fired up about KBLB again? Well earlier this month KBLB released some very promising news that, "it signed a commercial license agreement with the University of Notre Dame regarding spider silk technologies. The agreement awards Kraig the exclusive worldwide commercial rights to certain spider silk technologies which the Company jointly developed with the University of Notre Dame. Pursuant to the agreement, the University of Notre Dame will become a shareholder of the Company. The University will also receive a 2% royalty of the Company's net sales of products which incorporate the technology.

The subject of the agreement is the definitive spelling out of rights for the commercialization of what the Company refers to as "generation one" spider silk technology. The agreement confirms the Company's exclusive right to the commercial development of spider silk textiles derived from the subject technology. "Due to the significance of this technology it was important that we craft an agreement that benefits Kraig, our shareholders and the University," stated Kim Thompson, Company CEO and founder. "We are very happy to welcome the University of Notre Dame as our newest shareholder. We are also very happy to formally consummate this commercial license agreement covering the commercial rights to this exciting technology which we have been developing with the University."

"Our collaboration with university laboratories has been fundamental to the rapid progress we have made in the development of spider silk," Thompson continued. "The commercial license agreement reflects that sentiment and lays the groundwork for the Company's commercialization of spider silk technologies." ".
<Click here to read full news release>.  

You can continue your research, view their science and technology here.

Again put KBLB immediately on your radars tomorrow morning as we monitor the current technicals and corporate developments this week!

About Kraig Biocraft Laboratories, Inc.:
Kraig Biocraft Laboratories, Inc. ( is a fully reporting biotechnology company that recently achieved a series of scientific breakthroughs, with implications for the global textile industry.


"Finding Value in the Undervalued"
We work hard to research promising companies in all exchanges. Read our independent research here!

Never invest in any stock featured on our site or newsletter unless you can afford to lose your entire investment. Please remember that this newsletter is intended for commercial advertising, business media marketing and is for informational purposes only. None of the profiles issued by constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor as these are our opinions. Any investor should determine whether a particular security is suitable based on the investor’s objectives, other securities holdings, financial situation needs, and tax status.  The disclaimer is to be read and fully understood as a double opt-in subscriber as we do not tolerate spam. Please note well that employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at 
Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The third party, may have shares and may liquidate it, which may negatively affect the stock price. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies., nor any of its affiliates are not registered investment advisors or a broker dealers. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. does not offer such advice or analysis, and further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. From time to time we are compensated for commercial advertising and business media marketing or providing our own independent research coverage and opinions, full disclosure can be found in accordance with section 17(b) of the Securities Act of 1933 at every publication. has been compensated twenty five thousand dollars to provide one week of commercial advertising and business media marketing from our strategic corporate communication services for Kraig Biocraft Laboratories Inc. by Hansel Trust. We own no shares. If we are ever compensated, this compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. may from time to time, trade securities mentioned on our profiles covered by our own independent research where we are not compensated for any coverage or compensated. Public disclosure, by any means, of future coverage, ratings changes, and/or changes in earnings estimates prior to publication is prohibited as we will always disclose fully. In preparing this publication, has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. is not responsible for any claims made by the companies advertised here and are our own opinions.


Listen with webReader

Join our Free Newsletter!